Cost implications of PSA screening differ by age

BACKGROUND: Multiple guidelines seek to alter rates of prostate-specific antigen (PSA)-based prostate cancer screening. The costs borne by payers associated with PSA-based screening for men of different age groups—including the costs of screening and subsequent diagnosis, treatment, and adverse even...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Urol
Egile Nagusiak: Rao, Karthik, Liang, Stella, Cardamone, Michael, Joshu, Corinne E., Marmen, Kyle, Bhavsar, Nrupen, Nelson, William G., Ballentine Carter, H., Albert, Michael C., Platz, Elizabeth A., Pollack, Craig E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5944051/
https://ncbi.nlm.nih.gov/pubmed/29743049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0344-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak